撒哈拉以南非洲的癌症:柳叶刀肿瘤学委员会报告
报告详述该地区癌症现状,基于分析提出关键行动建议,并展示可推广的成功案例与模式。
要点
- 建议各国制定或更新国家癌症控制计划,涵盖儿童癌症、HIV与营养不良等合并症管理及药物可靠供应。
- 计划应纳入心理社会、支持与姑息治疗,并衔接逾80%人口使用的传统、补充与替代医学实践。
核心结论
- 实施本委员会推荐行动对减少撒哈拉以南非洲日益严重的癌症危机、实现联合国可持续发展目标中到2030年将非传染性疾病过早死亡减少三分之一的承诺至关重要。
研究设计与样本
- 柳叶刀肿瘤学委员会报告,基于数据分析详述撒哈拉以南非洲癌症现状并提出关键行动建议。
主要发现
- 在COVID-19大流行期间使用的一些方法(如大分割放疗和远程医疗)的投资和更广泛采用,可大幅增加非洲癌症治疗可及性、加速癌症预防与控制、提高生存率,并在未来十年节省数十亿美元。
- 撒哈拉以南非洲逾80%人口使用传统、补充与替代医学实践。
关键数值与推荐
- 建议首先在每个国家制定或更新国家癌症控制计划。
- 计划必须包括儿童癌症计划、管理HIV和营养不良等合并症、可靠且可预测的药物供应,以及提供心理社会、支持与姑息治疗。
- 计划应衔接逾80%撒哈拉以南非洲人口使用的传统、补充与替代医学实践,以及减少漏诊和迟转诊的路径。
- 需要对发展癌症登记和核心癌症检测的诊断进行更实质性投资。
- 应将全民健康覆盖扩展至将癌症纳入基本福利包。
临床怎么用
- 报告建议在撒哈拉以南非洲扩大对COVID-19大流行期间使用的大分割放疗和远程医疗等方法的投资与采用,以增加癌症治疗可及性。
- 报告建议加强非洲第一夫人参与癌症预防工作,并在撒哈拉以南非洲推广。
- 报告指出对劳动力培训的投资对到2030年预防数百万可避免死亡至关重要。
- 报告提出一个框架,用于战略规划撒哈拉以南非洲癌症研究增强,投资可产生投资回报并帮助推动政策与有效合作。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality. Without rapid interventions, data estimates show a major increase in cancer mortality from 520 348 in 2020 to about 1 million deaths per year by 2030. Here, we detail the state of cancer in SSA, recommend key actions on the basis of analysis, and highlight case studies and successful models that can be emulated, adapted, or improved across the region to reduce the growing cancer crises. Recommended actions begin with the need to develop or update national cancer control plans in each country. Plans must include childhood cancer plans, managing comorbidities such as HIV and malnutrition, a reliable and predictable supply of medication, and the provision of psychosocial, supportive, and palliative care. Plans should also engage traditional, complementary, and alternative medical practices employed by more than 80% of SSA populations and pathways to reduce missed diagnoses and late referrals. More substantial investment is needed in developing cancer registries and cancer diagnostics for core cancer tests. We show that investments in, and increased adoption of, some approaches used during the COVID-19 pandemic, such as hypofractionated radiotherapy and telehealth, can substantially increase access to cancer care in Africa, accelerate cancer prevention and control efforts, increase survival, and save billions of US dollars over the next decade. The involvement of African First Ladies in cancer prevention efforts represents one practical approach that should be amplified across SSA. Moreover, investments in workforce training are crucial to prevent millions of avoidable deaths by 2030. We present a framework that can be used to strategically plan cancer research enhancement in SSA, with investments in research that can produce a return on investment and help drive policy and effective collaborations. Expansion of universal health coverage to incorporate cancer into essential benefits packages is also vital. Implementation of the recommended actions in this Commission will be crucial for reducing the growing cancer crises in SSA and achieving political commitments to the UN Sustainable Development Goals to reduce premature mortality from non-communicable diseases by a third by 2030.
引用
- Ngwa W, Addai BW, Adewole I, et al. Cancer in sub-Saharan Africa: a Lancet Oncology Commission. Lancet Oncol. 2022. PMID: 35550267. doi:10.1016/S1470-2045(21)00720-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。